Effects of chemoradiotherapy on surface PD-L1 expression in esophageal cancer and its implications for immunotherapy.
- DOI
- 10.3389/fimmu.2024.1509051
- Published
- 2024-12-23
- Container
- Front Immunol
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2024.1509051,
title = {Effects of chemoradiotherapy on surface PD-L1 expression in esophageal cancer and its implications for immunotherapy.},
author = {Hampe L and Küffer S and Niemeier T and Scheele NC and Hampe LZ and Riedl AL and Fischer LA and Ziegler DA and Leu M and Dröge LH and König A and Ghadimi M and Braulke F and Rieken S and Bohnenberger H and El Shafie RA.},
year = {2024},
journal = {Front Immunol},
doi = {10.3389/fimmu.2024.1509051},
url = {https://doi.org/10.3389/fimmu.2024.1509051}
}RIS
TY - JOUR TI - Effects of chemoradiotherapy on surface PD-L1 expression in esophageal cancer and its implications for immunotherapy. AU - Hampe L AU - Küffer S AU - Niemeier T AU - Scheele NC AU - Hampe LZ AU - Riedl AL AU - Fischer LA AU - Ziegler DA AU - Leu M AU - Dröge LH AU - König A AU - Ghadimi M AU - Braulke F AU - Rieken S AU - Bohnenberger H AU - El Shafie RA. PY - 2024 JO - Front Immunol DO - 10.3389/fimmu.2024.1509051 UR - https://doi.org/10.3389/fimmu.2024.1509051 ER -
APA
L, H., S, K., T, N., NC, S., LZ, H., AL, R., LA, F., DA, Z., M, L., LH, D., A, K., M, G., F, B., S, R., H, B., & RA., E. S. (2024). Effects of chemoradiotherapy on surface PD-L1 expression in esophageal cancer and its implications for immunotherapy.. Front Immunol. https://doi.org/10.3389/fimmu.2024.1509051
Source records
- europe-pmc · retrieved 2026-09-27T10:47:07.292Z